Actinium Announces Pricing of Public Offering of Common Stock and Warrants to Purchase Common Stock Feb 6, 2015
Actinium Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock Feb 5, 2015
Actinium Engages Dr. Roland Turck, Former President, Global Specialty Medicine, Bayer Healthcare as Board Advisor Feb 4, 2015
Actinium to Participate in the Canaccord Genuity Rare Disease and Biopharma One-on-One Day on February 3rd Jan 28, 2015
Actinium Submits CMC Meeting Request to FDA for Iomab-B to Support IND Filing and Anticipated Commencement of Phase 3 Trial in Mid-2015 Jan 20, 2015
Actinium's Scientific Advisory Board Endorses and Supports the Iomab-B Phase 3 Clinical Trial Development Program Dec 9, 2014
